{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-230925","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.955744+00:00","generated_at":"2026-05-17T04:35:23.842076+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Stoke Therapeutics appoints Ian F. Smith as permanent CEO; interim role since March 2025","bullets":["Ian F. Smith, 59, appointed CEO effective Oct 6, 2025; served as interim CEO since March 19, 2025.","Annual base salary of $715,000; eligible for annual bonus target of 65% of base salary (no 2025 bonus).","Receives $500,000 sign-on bonus (repayable if resigns within 12 months) and $500,000 performance bonus based on metrics.","Equity grant: option for 570,000 shares (4-yr vest) and RSU for 380,000 shares (4-yr annual vest).","Dr. Tzianabos resigns as Interim Executive Chair, resumes as independent director and Chair of the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-230925","json":"https://secwatch.observer/filing/0001193125-25-230925.json","markdown":"https://secwatch.observer/filing/0001193125-25-230925.md","text":"https://secwatch.observer/filing/0001193125-25-230925.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312525230925/0001193125-25-230925-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312525230925/d55930d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:35:23.842076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}